Advertisement

Brain Trace Amines

  • Alan A. Boulton
  • Augusto V. Juorio

Abstract

The neologism “trace amines” was first adopted by a study group held under the auspices of the American College of Neuropsychopharmacology at its Puerto Rico meeting in 1975. The first book1 on this topic recorded the papers presented by the participants of this study group. The definition of a trace amine2 appears to include those monoamines whose tissue concentrations lie between 0.1 and 100 ng/g. That it is an inappropriate term follows from the fact that some of the well-known trace amines can exist in some tissues in amounts considerably in excess of 100 ng/g and indeed, in the presence of appropriate monoamine oxidase inhibitors, many of them exceed this level; it is also a fact that some of the well-known putative monoamine neurotransmitters may be present in trace quantities in some locations.

Keywords

Antipsychotic Drug Monoamine Oxidase Caudate Nucleus Monoamine Oxidase Inhibitor Optic Lobe 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Usdin, E., and Sandler, M. (eds.), 1976, Trace Amines and the Brain, Marcel Dekker, New York.Google Scholar
  2. 2.
    Boulton, A. A., 1974, Lancet 2: 7871.Google Scholar
  3. 3.
    Durden, D. A., and Philips, S. R., 1980, J. Neurochem. 34: 1725–1732.PubMedCrossRefGoogle Scholar
  4. 4.
    Boulton, A. A., 1976, Trace Amines and the Brain, (E. Usdin and M. Sandler. eds.), Marcel Dekker, New York, pp. 21–39.Google Scholar
  5. 5.
    Boulton, A. A., 1979, Behay. Brain Sci. 2: 418.CrossRefGoogle Scholar
  6. 6.
    Durden, D. A., Davis, B. A., and Boulton, A. A., 1974, Biomed. Mass Spectrom. 1: 83–95.PubMedCrossRefGoogle Scholar
  7. 7.
    Durden, D. A., 1978, Research Methods in Neurochemistry, Volume 4 (N. Marks and R. Rodnight, eds.), Plenum Press, New York, pp. 205–250.CrossRefGoogle Scholar
  8. 8.
    Durden, D. A., and Boulton, A. A., 1979, Techniques in the Life Sciences B2/11 (H. L. Kornberg, H. Metcalfe, D. Northcote, C. Pogson, and K. Tipton, eds.), Elsevier/North Holland, Amsterdan, pp. B214 1–25.Google Scholar
  9. 9.
    Davis, B. A., Durden, D. A., and Boulton, A. A., 1980, Recent Advances in Mass Sprectrometry and Medicine, Volume 6 ( D. Frigerio and M. McCamish, eds.), Elsevier/North Holland, Amsterdam, pp. 83–93.Google Scholar
  10. 10.
    Willner, J., LeFevre, H. F., and Costa, E., 1974, J. Neurochem. 23: 857–859.CrossRefGoogle Scholar
  11. 11.
    Warsh, J. J., Godse, D. D., Stancer, H. C., Chan, P. N., and Coscina, D. V., 1977, Biochem. Med. 18: 10–20.PubMedCrossRefGoogle Scholar
  12. 12.
    Karoum, F., Nasrallah, H., Potkin, S., Chuang, L., Moyer-Schwing, J., Phillips, I., and Wyatt, R. J., 1979, J. Neurochem., 33: 201–212.PubMedCrossRefGoogle Scholar
  13. 13.
    Danielson, T. J., Boulton, A. A., and Robertson, H. A., 1977, J. Neurochem. 29: 1131–1135.PubMedCrossRefGoogle Scholar
  14. 14.
    McCaman, M. W., and McCaman, R. E., 1978, Brain Res. 141: 347–352.PubMedCrossRefGoogle Scholar
  15. 15.
    David, J. C., and Delacour, J., 1980, Brain Res. 195: 231–235.PubMedCrossRefGoogle Scholar
  16. 16.
    Philips, S. R., 1981, Advances in Cellular Neurobiology, Volume 2 (L. Hertz and S. Federoff, eds.), Academic Press, New York pp. 355–391.Google Scholar
  17. 17.
    Saavedra, J. M., 1974, J. Neurochem. 22: 211–216.PubMedCrossRefGoogle Scholar
  18. 18.
    Suzuki, O., and Yagi, K., 1976, Anal. Biochem. 75: 192–200.PubMedCrossRefGoogle Scholar
  19. 19.
    Martin, I. L., and Baker, G. B., 1976, J. Chromatogr. 123: 45–50.PubMedCrossRefGoogle Scholar
  20. 20.
    Baker, G. B., Coutts, R. T., and LeGatt, D. F., 1980, Can. J. Neurol. Sci. 7: 235.Google Scholar
  21. 21.
    Barger, G., and Dale, H. H., 1910, J. Physiol. ( Lond. ) 41: 19–59.Google Scholar
  22. 22.
    Asatoor, A. M., and Dalgliesh, C. E., 1959, Biochem. J. 73: 26 P.Google Scholar
  23. 23.
    Jepson, J. B., Lovenberg, W., Zaltzman, P., Oates, J. A., Sjoerdsma, A., and Udenfriend, S., 1960, Biochem. J. 74: 5 P.Google Scholar
  24. 24.
    Randrup, A., and Munkvad, I., 1966, Acta Psychiat. Scand. [Suppl.] 191: 193–199.CrossRefGoogle Scholar
  25. 25.
    Fischer, E., Ludmer, R. I., and Sabelli, H. C., 1967, Acta Physiol. Lat. Am. 17: 15–21.Google Scholar
  26. 26.
    Mantegazza, P., and Riva, M. J., 1963, J. Pharm. Pharmacol. 15: 472–478.Google Scholar
  27. 27.
    Philips, S. R., Rozdilsky, B., and Boulton, A. A., 1978, Biol. Psychiatry 13: 51–57.PubMedGoogle Scholar
  28. 28.
    Mosnaim, A. D., and Luwang, E. E., 1973, Anal. Biochem. 54: 561–577.PubMedCrossRefGoogle Scholar
  29. 29.
    Durden, D. A., Philips, S. R., and Boulton, A. A., 1973, Can. J. Biochem. 51: 995–1002.PubMedCrossRefGoogle Scholar
  30. 30.
    Saavedra, J. M., 1974, Anal. Biochem. 59: 628–633.PubMedCrossRefGoogle Scholar
  31. 31.
    Philips, S. R., Durden, D. A., and Boulton, A. A., 1974a, Can. J. Biochem. 52: 366–373.PubMedCrossRefGoogle Scholar
  32. 32.
    Philips, S. R., Davis, B. A., Durden, D. A., and Boulton, A. A., 1975, Can. J. Biochem. 53: 65–69.PubMedCrossRefGoogle Scholar
  33. 33.
    Molinoff, P. B., and Axelrod, J., 1969, Science 164: 428–429.PubMedCrossRefGoogle Scholar
  34. 34.
    Philips, S. R., Durden. D. A., and Boulton, A. A., 1974, Can. J. Biochem. 52: 447–451.PubMedGoogle Scholar
  35. 35.
    Saavedra, J. M., and Axelrod, J., 1972, J. Pharmacol. Exp. Ther. 182: 363–369.Google Scholar
  36. 36.
    Tallman, J. F., Saavedra, J. M.. and Axelrod, J., 1976, J. Pharmacol. Exp. Ther. 199: 216–221.Google Scholar
  37. 37.
    Sloan, J. M., Martin, W. R., Clements, T. H., Buchwald, W. F., and Bridges, S. R., 1975, J. Neurochem. 24: 523–532.PubMedCrossRefGoogle Scholar
  38. 38.
    Fischer, E., Spatz, H., Heller, B., and Reggiani, H., 1972, Experientia 28: 307–308.PubMedCrossRefGoogle Scholar
  39. 39.
    Snodgrass, S. R., and Horn, A. S., 1973, J. Neurochem. 21: 687–696.PubMedCrossRefGoogle Scholar
  40. 40.
    Boulton, A. A., Juorio, A. V., Philips, S. R., and Wu, P. H., 1975, Brain Res. 96: 212–216.PubMedCrossRefGoogle Scholar
  41. 41.
    Borison, R. L., Mosnaim, A. D., and Sabelli, H. C., 1974, Life Sci. 15: 1837–1848.PubMedCrossRefGoogle Scholar
  42. 42.
    Faraj, B. A., Mu, J.-Y., Lewis, M. S., Wilson, J. P., Israili, Z. H., and Dayton, P. G., 1975, Proc. Soc. Exp. Biol. Med. 149: 664–669.Google Scholar
  43. 43.
    Mosnaim, A. D., Inwang, E. E., and Sabelli, H. C., 1974, Biol. Psychiatry 8: 227–234.PubMedGoogle Scholar
  44. 44.
    Gunne, L.-M., and Jonsson, J., 1965, Acta Physiol. Scand. 64: 434–438.PubMedCrossRefGoogle Scholar
  45. 45.
    Juorio, A. V., 1976, Brain Res. 111: 442–445.PubMedCrossRefGoogle Scholar
  46. 46.
    Juorio, A. V., and Philips, S. R., 1976, Neurochem. Res. 1: 501–509.CrossRefGoogle Scholar
  47. 47.
    Robertson, H. A., 1976, Experientia 32: 552–553.PubMedCrossRefGoogle Scholar
  48. 48.
    Juorio, A. V., and Robertson, H. A., 1977, J. Neurochem. 28: 573–579.PubMedCrossRefGoogle Scholar
  49. 49.
    Danielson, T. J.. Wishart, T. B., and Boulton, A. A., 1976. Life Sci. 18: 1237–1244.PubMedCrossRefGoogle Scholar
  50. 50.
    Boulton, A. A., Juorio, A. V., Philips, S. R., and Wu, P. H., 1977, Br. J. Pharmacol. 59: 209–214.PubMedCrossRefGoogle Scholar
  51. 51.
    Philips, S. R., 1978, Noncatecholic Phenylethylamines (A. D. Mosnaim, and M. E. Wolf, eds.), Marcel Dekker, New York and Basel, pp. 113–138.Google Scholar
  52. 52.
    Juorio, A. V., and Danielson, T. J., 1978, Eur. J. Pharmacol. 50: 79–82.PubMedCrossRefGoogle Scholar
  53. 53.
    Spector, S., Melmon, K., Lovnberg, W., and Sjoerdsma, A., 1963, J. Pharmacol. Exp. Ther. 140: 229–235.Google Scholar
  54. 54.
    Wu, P. H., and Boulton, A. A., 1975, Can. J. Biochern. 53: 42–50.CrossRefGoogle Scholar
  55. 55.
    Giardina, W. J., Pedemonte, W. A., and Sabelli, H. C., 1973, Life Sci. 12: 153–161.CrossRefGoogle Scholar
  56. 56.
    Henwood, R. W., Boulton, A. A., and Phillis, J. W., 1979, Brain Res. 164: 247–351.CrossRefGoogle Scholar
  57. 57.
    Jones, R. S. G., and Boulton, A. A., 1980, Can. J. Physiol. Pharmacol. 58: 222–227.Google Scholar
  58. 58.
    Snodgrass, S. R., 1974, J. Pharm. Pharmacol. 26: 931–936.Google Scholar
  59. 59.
    Philips, S. R., and Boulton, A. A., 1979, J. Neurochem. 33: 159–167.PubMedCrossRefGoogle Scholar
  60. 60.
    Yang, H.-Y. T., and Neff, N. H., 1973, J. Pharmacol. Exp. Ther. 187: 365–371.Google Scholar
  61. 61.
    Boulton, A. A., 1979, Int. Rev. Biochem. 26: 179–206.Google Scholar
  62. 62.
    Oldendorf, W. H., 1971, Am. J. Physiol. 221: 1629–1639.PubMedGoogle Scholar
  63. 63.
    Boulton, A. A., and Baker, G. B., 1975, J. Neurochem. 25: 477–481.PubMedCrossRefGoogle Scholar
  64. 64.
    Shore, P. A., Silver, S. L., and Brodie, B. B., 1955, Science 122: 284–285.PubMedCrossRefGoogle Scholar
  65. 65.
    Holzbauer, M., and Vogt, M., 1956, J. Neurochem. 1: 8 - I1.PubMedCrossRefGoogle Scholar
  66. 66.
    Bertler, A., 1961, Acta Physiol. Scand. 51: 75–83.CrossRefGoogle Scholar
  67. 67.
    Fuxe, K., Grobecker, H., and Jonsson, J., 1967, Eur. J. Pharmacol. 2: 202–207.PubMedCrossRefGoogle Scholar
  68. 68.
    Jonsson, J., Grobecker, H., and Holtz, P., 1966, Life Sci. 5: 2235–2246.CrossRefGoogle Scholar
  69. 69.
    Jackson, D. M., and Smythe, D. B., 1973, Neuropharmacology 12: 663–668.PubMedCrossRefGoogle Scholar
  70. 70.
    Baker, G. B., Raiteri, M., Bertollini, A., Del Carmine, R., Keane, P. E., and Martin, I. L., 1976, J. Pharm. Pharmacol. 28: 456–457.Google Scholar
  71. 71.
    Schmitt, R., and Nasse, O., 1865, Liebigs Ann. Chem. 133: 211–216.CrossRefGoogle Scholar
  72. 72.
    Barger, G., 1909, J. Chem. Soc. 95: 1123–1129.Google Scholar
  73. 73.
    Henze, M., 1913, Hoppe Seylers Z. Physiol. Chem. 87: 51–58.Google Scholar
  74. 74.
    Nishimura, T., and Gjessing, L. R., 1966, Scand. J. Clin. Lab. Invest. 18: 217–220.Google Scholar
  75. 75.
    King, G. S., Goodwin, B. L., Ruthven, C. R. J., and Sandler, M., 1974, Clin. Chim. Acta 51: 105–107.Google Scholar
  76. 76.
    Boulton, A. A., Dyck, L. E., and Durden, D. A., 1974, Life Sci. 15: 1673–1683.PubMedCrossRefGoogle Scholar
  77. 77.
    Boulton, A. A., and Dyck, L. E., 1974, Life Sci. 14: 2497–2506.PubMedCrossRefGoogle Scholar
  78. 78.
    Mitoma, C., Posner, H. S., Bogdanski, D. F., and Udenfriend, S., 1957, J. Pharmacol. Exp. Ther. 120: 188–194.Google Scholar
  79. 79.
    Majer, J. R., and Boulton, A. A., 1970, Nature 225: 658–660.PubMedCrossRefGoogle Scholar
  80. 80.
    Boulton, A. A., and Majer, J. R., 1970, J. Chromatogr. 48: 322–327.PubMedCrossRefGoogle Scholar
  81. 81.
    Boulton, A. A., and Majer, J. R., 1971, Can. J. Biochem. 49: 993–998.PubMedCrossRefGoogle Scholar
  82. 82.
    Faraj, B. A., Dayton, P. G., Camp, V. M., Wilson, J. P.. Maivean, E. J., and Schlant, R. C., 1977, J. Pharmacol. Exp. Ther. 200: 384–393.Google Scholar
  83. 83.
    Tallman, J. C., Saavedra, J. M., and Axelrod, J., 1976, J. Neurochem. 27: 465–469.PubMedCrossRefGoogle Scholar
  84. 84.
    Juorio, A. V., 1977, Brain Res. 126: 181–184.PubMedCrossRefGoogle Scholar
  85. 85.
    Juorio, A. V., 1977, Life Sci. 20: 1663–1668.PubMedCrossRefGoogle Scholar
  86. 86.
    Juorio, A. V., 1979, Br. J. Pharmacol. 66: 377–384.PubMedCrossRefGoogle Scholar
  87. 87.
    Juorio, A. V., 1980, Br. J. Pharmacol. 70: 475–480.PubMedCrossRefGoogle Scholar
  88. 88.
    Bevan, P., Bradshaw, C. M., Pun, R. Y. K., Slater, N. T., and Szabadi, E., 1978, Br. J. Pharmacol. 63: 651–657.PubMedCrossRefGoogle Scholar
  89. 89.
    Boulton, A. A., and Wu, P. H., 1973, Can. J. Biochem. 51: 428–435.PubMedCrossRefGoogle Scholar
  90. 90.
    Fellman, J. H., Roth, G. S., and Fujita, T. S., 1976, Arch. Biochem. Biophys. 174: 562–567.Google Scholar
  91. 91.
    Boulton, A. A., and Quan, L., 1970, Can. J. Biochem. 48: 1287–1291.PubMedCrossRefGoogle Scholar
  92. 92.
    Brandau, K., and Axelrod, J., 1972, Naunyn-Schmiedebergs Arch. Pharmacol. 273: 123–133.Google Scholar
  93. 93.
    Silkaitis, R. P., and Mosnaim, A. D., 1976, Brain Res. 114: 105–115.PubMedCrossRefGoogle Scholar
  94. 94.
    Mosnaim, A. D., Edstrand, D. L., Wolf, M. E., and Silkaitis, R. P., 1977, Biochem. Pharmacol. 26: 1725–1728.PubMedCrossRefGoogle Scholar
  95. 95.
    Davis, B. A., and Boulton, A. A., 1980, Eur. J. Mass Spectrom. Med. Envir. Res. 1: 149–153.Google Scholar
  96. 96.
    Ewins, A. J., and Laidlaw, P. P., 1910, J. Physiol., 41: 78–87.PubMedGoogle Scholar
  97. 97.
    Blaschko, H., Richter, D., and Schlossmann, H., 1937, Biochem. J. 31: 2187–2196.PubMedGoogle Scholar
  98. 98.
    Yu, P. H., and Boulton, A. A., 1980, J. Neurochem. 35: 255–257.PubMedCrossRefGoogle Scholar
  99. 99.
    Wu, P. H., and Boulton, A. A., 1974, Can. J. Biochem. 52: 374–381.PubMedCrossRefGoogle Scholar
  100. 100.
    Philips, S. R., Baker, G. B., and McKim, H. R., 1980, Experientia 36: 241–242.PubMedCrossRefGoogle Scholar
  101. 101.
    Juorio, A. V., Davis, B. A., and Boulton, A. A., 1980, Res. Commun. Psychol. Psychiatry Behay. 5: 255–264.Google Scholar
  102. 102.
    Durden, D. A., and Boulton, A. A., 1981, J. Neurochem. 36: 129–135.PubMedCrossRefGoogle Scholar
  103. 103.
    Davis, B. A., Durden, D. A., Li, P. P., and Boulton, A. A., 1977, J. Chromatogr. 142: 517–522.PubMedCrossRefGoogle Scholar
  104. 104.
    McQuade, P. S., Juorio, A. V., and Boulton, A. A., 1981, J. Neurochem. 37: 735–739.PubMedCrossRefGoogle Scholar
  105. 105.
    Karoum, F., Gillin, J. C., Wyatt, R. J., and Costa, E., 1975, Biomed. Mass Spectrom. 2: 183–189.CrossRefGoogle Scholar
  106. 106.
    Karoum, F., Wyatt, R. J., and Majchrowicz, E., 1976, Br. J. Pharmacol. 56: 403–411.PubMedCrossRefGoogle Scholar
  107. 107.
    Yu, P. H., and Boulton, A. A., 1979, Can. J. Biochem. 57: 1204–1209.PubMedCrossRefGoogle Scholar
  108. 108.
    Buck, S. H., Murphy, R., and Molinoff, P. B., 1977, Brain Res., 122: 281–297.PubMedCrossRefGoogle Scholar
  109. 109.
    Harmar, A. J., and Horn, A. S., 1976, J. Neurochem., 26: 987–993.PubMedCrossRefGoogle Scholar
  110. 110.
    Juorio, A. V., 1980, Catecholamines and Stress: Recent Advances (E. Usdin, R. Kvetnansky, and I. J. Kopin, eds.), Pergamon Press, Oxford, pp. 423–426.Google Scholar
  111. 111.
    Commarato, M. A., Brody, T. M., and McNeil, J. H., 1969, Can. J. Physiol. Pharmacol. 47: 511–514.Google Scholar
  112. 112.
    Steinberg, M. I., and Smith, C. B., 1971, J. Pharmacol. Exp. Ther. 176: 139–148.Google Scholar
  113. 113.
    Ross, S. B., and Renyi, A. L., 1971, J. Pharm. Pharmacol., 23: 276–279.Google Scholar
  114. 114.
    Lentzen, H., and Phillippu, A., 1977, Naunyn Schmiedebergs Arch. Pharmacol., 300: 25–30.Google Scholar
  115. 115.
    Dyck, L. E., 1978, Neurochem. Res., 3: 775–791.PubMedCrossRefGoogle Scholar
  116. 116.
    Petrali, E. H., Boulton, A. A., and Dyck, L. E., 1979, Neurochem. Res. 4: 633–642.PubMedCrossRefGoogle Scholar
  117. 117.
    Petrali, E. H., 1979, Neurochem. Res. 5: 297–300.CrossRefGoogle Scholar
  118. 118.
    Stoof, J. C., Liem, A. L., and Mulder, A. H., 1976, Arch. Int. Pharmacodyn. Ther. 220: 62–71.Google Scholar
  119. 119.
    Dyck, L. E., and Boulton, A. A., 1980, Res. Commun. Psychol. Psychiatry Behay., 5: 61–78.Google Scholar
  120. 120.
    Boulton, A. A., and Dyck, L. E., 1980, Res. Commun. Psycho!. Psychiatry Behay. 5: 79–94.Google Scholar
  121. 121.
    Arbilla, S., Kamal, L. A., and Langer, S. Z., 1981, Br. J. Pharmacol. 72: 499P - 500 P.Google Scholar
  122. 122.
    Dyck, L. E., Boulton, A. A., and Jones, R. S. G., 1980, Eur. J. Pharmacol. 68: 33–40.PubMedCrossRefGoogle Scholar
  123. 123.
    Dyck, L. E., 1981, Eur. J. Pharmacol. 69: 371–374.PubMedCrossRefGoogle Scholar
  124. 124.
    Juorio, A. V., 1979, Brain Res. 179: 186–189.PubMedCrossRefGoogle Scholar
  125. 125.
    Dyck, L. E., 1981, Neurochem. Res. 6: 365–375.PubMedCrossRefGoogle Scholar
  126. 126.
    Boulton, A. A., and Juorio, A. V., 1979, Biol. Psychol. 14: 413–419.Google Scholar
  127. 127.
    Randrup, A., Munkvad, 1., and Usden, P., 1963, Acta Pharmacol. Toxicol. ( Kbh. ) 20: 143–157.Google Scholar
  128. 128.
    Espelin, D. E., and Done, A. K., 1968, N. Eng. J. Med. 278: 1361–1365.Google Scholar
  129. 129.
    Costa, E., Groppetti, A., and Naimzada, M. K., 1972, Br. J. Pharmacol. 44: 742–751.PubMedCrossRefGoogle Scholar
  130. 130.
    Carlsson, A., and Lindquist, M., 1963, Acta Pharmacol. Toxicol. 20: 140–144.CrossRefGoogle Scholar
  131. 131.
    Andén, N.-E., Roos, B.-E., and Werdinius, B., 1964, Life Sci. 3: 149–158.CrossRefGoogle Scholar
  132. 132.
    Laverty, R., and Sharman, D. F., 1965, Br. J. Pharm., 24: 759–772.Google Scholar
  133. 133.
    O Keeffe, R., Sharman, D. F., and Vogt. M., 1970, Br. J. Pharmacol. 38: 287–304.CrossRefGoogle Scholar
  134. 134.
    Roos, B.-E., 1969, J. Pharm. Pharmacol. 21: 263–264.Google Scholar
  135. 135.
    Corrodi, H., Fuxe, K., and Ungerstedt, U., 1971, J. Pharm. Pharmacol. 23: 989–991.Google Scholar
  136. 136.
    Fuller, R. W., and Perry, K. W., 1978, J. Neural Transm. 42: 23–36.PubMedCrossRefGoogle Scholar
  137. 137.
    Spector, S., Sjoerdsma, A., and Udenfriend, S., 1965, J. Pharmacol. 147: 86–97.Google Scholar
  138. 138.
    Huebert, N. D., and Boulton, A. A., 1978, Res. Commun. Chem. Path. Pharmacol. 22: 73–82.Google Scholar
  139. 139.
    Inwang, E. E., Mosnaim, A. D., and Sabelli, H. C., 1973, J. Neurochem. 20: 1469–1473.PubMedCrossRefGoogle Scholar
  140. 140.
    Saavedra, J. M., and Axelrod, J., 1973, Proc. Natl. Acad. Sci. U.S.A. 70: 769–772.Google Scholar
  141. 141.
    Saavedra, J. M., Ribas, J., Swann, J., and Carpenter, D. 0., 1977, Science 195: 1004–1006.PubMedCrossRefGoogle Scholar
  142. 142.
    Erspamer, V., 1948, Acta Pharmacy!. Toxicol. ( Kbli. ) 4: 224–227.Google Scholar
  143. 143.
    Erspamer, V., 1952, Nature 169: 375–376.PubMedCrossRefGoogle Scholar
  144. 144.
    Kakimoto, Y., and Armstrong, M. D., 1962, J. Biol. Chem. 237: 422–427.Google Scholar
  145. 145.
    Juorio, A. V., 1978, Experientia 34: 1329–1330.PubMedCrossRefGoogle Scholar
  146. 146.
    Walker, R. J., Ramage, A. G., and Woodruff, G. N., 1972, Experientia 28: 1173–1174.PubMedCrossRefGoogle Scholar
  147. 147.
    Saavedra, J. M., Brownstein, M. J., Carpenter, D. O., and Axelrod. J., 1974, Science 185: 364–365.PubMedCrossRefGoogle Scholar
  148. 148.
    Juorio, A. V., and Molinoff, P. B., 1974, J. Neurochem. 22: 271–280.PubMedCrossRefGoogle Scholar
  149. 149.
    Barker, D. L., Molinoff, P. B., and Kravitz, E. A., 1972, Nature [New Biol.] 236: 61–63.CrossRefGoogle Scholar
  150. 150.
    Robertson, H. A., and Juorio, A. V., 1976, Int. Rev. Neurobiol. 19: 173–224.Google Scholar
  151. 151.
    Hicks, T. P., and McLennan, H., 1978, Br. J. Pharmacol. 64: 485–491.PubMedCrossRefGoogle Scholar
  152. 152.
    Hicks, T. P., and McLennan, H., 1980, Brain Res. 157: 402–406.CrossRefGoogle Scholar
  153. 153.
    Karoum, F., Gitlin, J. C., and Wyatt, R. J., 1975, J. Neurochem. 25: 653–658.PubMedCrossRefGoogle Scholar
  154. 154.
    Baldessarini, R. J., and Vogt, M., 1971, J. Neurochem. 18: 2519–2533.PubMedCrossRefGoogle Scholar
  155. 155.
    Baldessarini, R. J., and Vogt, M.. 1972, J. Neurochem. 19: 755–761.PubMedCrossRefGoogle Scholar
  156. 156.
    Durden, D. A., Juorio, A. V., and Davis, B. A., 1978, Quantitative Mass Spectrometry in Life Sciences II, Proceedings of the Second International Symposium (A. P. de Leenheer, R. R., Roncucci, and C. van Peteghem, eds.), Elsevier Scientific Publishing Company, Amsterdam, Oxford, New York, pp. 389–397.Google Scholar
  157. 157.
    Durden, D. A., Juorio, A. V., and Davis, B. A., 1980, Anal. Chem. 52: 1815–1820.PubMedCrossRefGoogle Scholar
  158. 158.
    Hess, S. M., Redfield, B. G., and Udenfriend, S., 1959, J. Pharmacol. Exp. Ther. 127: 178–181.Google Scholar
  159. 159.
    Eccleston, D., Ashcroft, G. W., Crawford, T. B. B., and Loose, R., 1966, J. Neurochem. 13: 93–101.PubMedCrossRefGoogle Scholar
  160. 160.
    Martin, W. R., Sloan, J. W., Christian, S. T. and Clements, T. H., 1972, Psychopharmacologia 24: 331–346.PubMedCrossRefGoogle Scholar
  161. 161.
    Jones, R. S. G., and Boulton, A. A., 1980 Life Sci. 27: 1849–1856.PubMedCrossRefGoogle Scholar
  162. 162.
    Wu, P. H., and Boulton, A. A., 1973, Can. J. Biochem. 51: 1104–1112.PubMedCrossRefGoogle Scholar
  163. 163.
    Warsh, J. J., Chan. P. W., Godse, D. D., Coscina, D. V., and Stancer, H. C., 1977, J. Neurochem. 29: 955–958.PubMedCrossRefGoogle Scholar
  164. 164.
    Young, S. N., Anderson. G. M., Gauthier, S., and Purdy, W. C., 1980, J. Neurochem. 34: 1087–1092.PubMedCrossRefGoogle Scholar
  165. 165.
    Faurbye, A., 1968, Compr. Psychiatry 9: 155–177.PubMedCrossRefGoogle Scholar
  166. 166.
    Connell, P. H., 1958, Amphetamine Psychosis, Chapman and Hall, London.Google Scholar
  167. 167.
    Snyder, S. H., 1973, Am. J. Psychiatry 130: 61–67.PubMedGoogle Scholar
  168. 168.
    Sandler, M., and Reynolds, G. P., 1976, Lancet 1: 70–71.PubMedCrossRefGoogle Scholar
  169. 169.
    Potkin, S. G., Karoum, F., Chuang, L. W., Cannon-Spoor, H. E., Phillips, I., and Wyatt. R. J., 1979, Science 206: 470–471.PubMedCrossRefGoogle Scholar
  170. 170.
    Wyatt, R. J., Gillis, J. C., Stoff, A. M., Majo, E. A., and Tinklenborg, J. R., 1977, Neuroregulators and Psychiatric Disorders (E. Usdin, D. A. Hamburg, and J. D. Barchas, eds.), Oxford University Press, New York, pp. 31–45.Google Scholar
  171. 171.
    Sandler, M., Ruthven, C. R. J., Goodwin, B. L., King, G. S., Pettit, B. R., and Reynolds, G. P., 1978, Commun. Psychopharmacol. 2: 199–202.PubMedGoogle Scholar
  172. 172.
    Sabelli, H. C., and Mosnaim, A. D., 1974, Am. J. Psychiatry 131: 695–699.PubMedGoogle Scholar
  173. 173.
    Sandler, M., Ruthven, C. R. J., Goodwin, B. C., Field, H., and Mathews. R., 1978, Lancet 2: 1269–1270.PubMedCrossRefGoogle Scholar
  174. 174.
    Edwards, D. J., and Blau, K., 1973, Biochem. J. 132: 95–100.PubMedGoogle Scholar
  175. 175.
    Reynolds, G. P., Seakins, J. W. T., and Gray, D. O., 1978, Clin. Chico. Acta 83: 33–39.Google Scholar
  176. 176.
    Sandler, M., Youdim, M. B. H., and Hanington, E., 1974, Nature 250: 335–337.PubMedCrossRefGoogle Scholar
  177. 177.
    Hanington, E., 1967, Br. Med. J. 2: 550–551.Google Scholar
  178. 178.
    Boulton, A. A., Majer, J. R., and Pollitt, R. J., 1967, Nature 215: 132–134.PubMedCrossRefGoogle Scholar
  179. 179.
    Smith, I., and Kellow, A. H., 1969, Nature 221: 1261.PubMedCrossRefGoogle Scholar
  180. 180.
    Boulton, A. A., and Marjerrison, G. L., 1972, Nature 236: 76–78.PubMedCrossRefGoogle Scholar
  181. 181.
    Boulton, A. A., Marjerrison, G. L., and Majer, J. R., 1971, J. Acad. Sci. ( USSR ) 5: 68–70.Google Scholar
  182. 182.
    Bonham-Carter, S., Sandler, M., Goodwin, B. L., Sepping, P., and Bridges, P. K., 1978, Br. J. Psychiatry 132: 125–132.CrossRefGoogle Scholar
  183. 183.
    Sandler, M., Ruthven, C. R. J., Goodwin, B. L., Reynolds, G. P., Rao, V. A. R., and Coppen, A., 1979, Nature 278: 357–358.PubMedCrossRefGoogle Scholar
  184. 184.
    Ghose, K., Turner, P., and Coppen, A., 1975, Lancet 1: 1317–1318.PubMedCrossRefGoogle Scholar
  185. 185.
    Pickar, A., Cohen, R. M., Murphy, D., and Fried, A., 1979, Am. J. Psychiatry 136: 1460–1463.PubMedGoogle Scholar
  186. 186.
    Blackwell, B., and Marley, E., 1964, Lancet 1: 530–531.PubMedCrossRefGoogle Scholar
  187. 187.
    Scott, D. F., Moffett, A., and Swash, M., 1972, Epilepsia 13: 365–375.PubMedCrossRefGoogle Scholar
  188. 188.
    Swash, M., Moffett, A. M., and Scott, A. F., 1975, Nature 258: 769–750.CrossRefGoogle Scholar
  189. 189.
    Slingsby, J. M., and Boulton, A. A., 1976, J. Chromatogr. 123: 51–56.PubMedCrossRefGoogle Scholar
  190. 190.
    Slingsby, J. M., 1975, Factors affecting urinary excretion of arylallylamines in a randomly selected psychiatric population, Ph.D. Thesis, University of Saskatchewan, Saskatoon.Google Scholar
  191. 191.
    Boulton, A. A., 1968, Prog. Neurogenet. 1: 437–441.Google Scholar
  192. 192.
    Huebert, N., and Boulton, A. A., 1979, J. Chromatogr. Biomed. Appl. 162: 169–176.Google Scholar
  193. 193.
    Davis, B. A., and Boulton, A. A., 1981, J. Chromatogr. Biomed. Appl. 222: 161–169.Google Scholar
  194. 194.
    Bremer, H. J., Jaenicke, U., and Lupold, D., 1969, Clin. Chim. Acta 23: 244–246.Google Scholar
  195. 195.
    Gjessing, L. R., and Lindeman, R., 1967, Lancet 2: 47–48.CrossRefGoogle Scholar
  196. 196.
    Gibbons, 1. S. E., Seakins, J. W. T., and Ersser, R. S., 1967, Lancet 1: 877–878.Google Scholar
  197. 197.
    Duckworth, T., Bond, P. A., McKibbin, B., and Mitchell, E. C., 1973, Clin. Chim. Acta 43: 249–255.Google Scholar
  198. 198.
    Fischer, J. E., and Baldessarini, R. J., 1971, Lancet 2: 75–80.PubMedCrossRefGoogle Scholar
  199. 199.
    Lam, K. C., Tall, A. R., Goldstein, G. B., and Mistilis, S. P., 1973, Scand. J. Gastroenterol. 8: 465–472.PubMedGoogle Scholar
  200. 200.
    Manghani, K. K., Lanzer, M. R., Billing, B. H., and Sherlock, S., 1975, Lancet 2: 943–946.PubMedCrossRefGoogle Scholar
  201. 201.
    Rossi-Fanelli, F., Cangiano, C., Attili, A., Angelico, M., Cascino, A., Capocaccia, L., Strom, R., and Crifo, C., 1976, Clin. Chim. Acta 67: 255–261.Google Scholar
  202. 202.
    Capocaccia, L., Cangiano, C., Attili, A. F., Angelico, M., Cascino, A., and Fanelli, F. R., 1977, Clin. Chim. Acta 75: 99–105.Google Scholar
  203. 203.
    Baldessarini, R. J., and Fischer, J. E., 1977, Arch. Gen. Psychiatry 34: 958–964.Google Scholar
  204. 204.
    Berlet, H. H., Pscheidt, G. R., Spaid, J. K., and Himwich, H. E., 1964, Nature 203: 1198–1199.PubMedCrossRefGoogle Scholar
  205. 205.
    Sullivan, J. L., Cottey, C. E., Basuk, B., Cavenar, J. D., Maltbie, A. A., and Zung, W. K., 1980, Biol. Psychiatry 15: 113–120.PubMedGoogle Scholar
  206. 206.
    Saavedra, S., and Axelrod, J., 1972, Science 175: 1365–1366.PubMedCrossRefGoogle Scholar
  207. 207.
    Morgan, M., and Mandell, A. J., 1969, Science 165: 492–493.PubMedCrossRefGoogle Scholar
  208. 208.
    Morgan, M., and Mandell, A. J., 1971, Nature [New Biol.] 230: 85.Google Scholar
  209. 209.
    Mandell, L. R., Rosenweig, S., and Kuehl, F., 1971, Biochem. Pharmacol. 20: 712–716.CrossRefGoogle Scholar
  210. 210.
    Mandell, L. R., Ahn, A. S., Vandenheuvel, N. J. A., and Walker, R. W., 1972, Biochem. Pharmacol. 21: 1197–1200.CrossRefGoogle Scholar
  211. 211.
    Young, S. N., and Lal, S., 1980, J. Neural Transm. 47: 153–161.PubMedCrossRefGoogle Scholar
  212. 212.
    Young, S. N., 1980, Enzymes and Neurotransmitters in Mental Disease (E. Usdin, T. L. Sourkes, and Q. M. B. H. Youdim, eds.), John Wiley & Sons, New York, pp. 247–260.Google Scholar
  213. 213.
    Domino, E. F., Matthews, B. N., and Tait, S. K., 1979, Biomed. Mass Spectrom. 6: 331–334.PubMedCrossRefGoogle Scholar
  214. 214.
    Yu, P. H., O’Sullivan, K. S., Keegan, D., and Boulton, A. A., 1980, Psychiatry Res. 3: 205–210.PubMedCrossRefGoogle Scholar
  215. 215.
    Yu, P. H., and Boulton, A. A., 1979, Life Sci. 25: 31–36.PubMedCrossRefGoogle Scholar
  216. 216.
    Boulton, A. A., 1980, Neurochemistry and Clinical Neurology (L. Battiskin, G. Hashin, and A. Lajtha, eds.), Alan R. Liss, New York, pp. 291–303.Google Scholar
  217. 217.
    Dismukes, R. K., 1979. Behay. Brain Sci. 2: 409–448.CrossRefGoogle Scholar
  218. 218.
    Juorio, A. V., and Jones, R. S. G., 1981, J. Neurochem. 36: 1898–1903.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1982

Authors and Affiliations

  • Alan A. Boulton
    • 1
  • Augusto V. Juorio
    • 1
  1. 1.Psychiatric Research DivisionUniversity HospitalSaskatoonCanada

Personalised recommendations